Cargando…
Could Galectin 3 Be a Good Prognostic Factor in Endometrial Cancer?
Galectin 3 is a modulator of several basic biological functions. It may be involved in the development of obesity and type 2 diabetes—risk factors of endometrial cancer. The study involved 144 patients, after abrasion due to postmenopausal bleeding. Galectin 3 concentrations were quantified in serum...
Autores principales: | Cymbaluk-Płoska, Aneta, Gargulińska, Paula, Kwiatkowski, Sebastian, Pius-Sadowska, Ewa, Machaliński, Bogusław |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7554825/ https://www.ncbi.nlm.nih.gov/pubmed/32859099 http://dx.doi.org/10.3390/diagnostics10090635 |
Ejemplares similares
-
The Suitability of FGF21 and FGF23 as New Biomarkers in Endometrial Cancer Patients
por: Cymbaluk-Płoska, Aneta, et al.
Publicado: (2020) -
Could Vaspin Be a Potential Diagnostic Marker in Endometrial Cancer?
por: Pietrzyk, Dominika, et al.
Publicado: (2023) -
Evaluation of Paraoxonase-1 and Pentraxin-3 in the Diagnosis and Prognosis of Endometrial Cancer
por: Kozłowski, Mateusz, et al.
Publicado: (2022) -
The role of lipocalin-2 serum levels in the diagnostics of endometrial cancer
por: Cymbaluk-Płoska, Aneta, et al.
Publicado: (2019) -
Clinical Significance of BTLA, CD27, CD70, CD28 and CD80 as Diagnostic and Prognostic Markers in Ovarian Cancer
por: Świderska, Janina, et al.
Publicado: (2022)